Anatomy Fund

An Israeli venture capital fund focused on investing in high-potential Israeli medical device companies.

Venture Capital Tel Aviv, Israel Est. 2012
Last updated 2026-11-10
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$2.0M
total disclosed, rounds participated
Stages
Seed, Early stage VC

About

Anatomy Medical Technology Fund is a venture capital fund managed by Clal Biotechnology Industries (CBI). It leverages financial resources and business expertise to invest in promising Israeli medical device companies. The fund operated in two stages, Anatomy Medical Technologies I and II, with investment periods ending in 2021. In 2021, CBI announced the sale of the Anatomy funds' portfolio (excluding Sight Diagnostics) to Almeda Ventures.

Portfolio · 1

Q&A

What is Anatomy Fund's primary investment focus?
Anatomy Fund is an Israeli venture capital fund focused on investing in high-potential Israeli medical device companies.
When was Anatomy Fund founded?
Anatomy Fund was founded in January 2012.
What is the status of Anatomy Fund's investment activity?
Anatomy Fund is currently inactive, with its investment periods for Anatomy Medical Technologies I and II ending in 2021.
Who managed Anatomy Medical Technology Fund?
Anatomy Medical Technology Fund was managed by Clal Biotechnology Industries (CBI).
What happened to Anatomy Fund's portfolio in 2021?
In 2021, Clal Biotechnology Industries (CBI) announced the sale of the Anatomy funds' portfolio (excluding Sight Diagnostics) to Almeda Ventures.
What investment stages did Anatomy Fund target?
Anatomy Fund targeted Seed and Early stage VC investments.
What sectors did Anatomy Fund prefer to invest in?
Anatomy Fund preferred to invest in the Medical Devices and Life Sciences sectors.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2012-1